These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 313293)

  • 21. Enhanced T-cell rosette formation in shigellosis by the in vitro use of thymopoietin.
    Jackson TM; Zaman SN
    Trans R Soc Trop Med Hyg; 1979; 73(6):677-9. PubMed ID: 317187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide.
    Diezel W; Waschke SR; Forner K
    Biomed Biochim Acta; 1984; 43(6):K9-12. PubMed ID: 6435610
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis of the nonatetracontapeptide corresponding to the entire amino acid sequence of thymopoietin III and its effect on the impaired T-lymphocyte transformation of a patient with common variable immunodeficiency.
    Abiko T; Shishido H; Sekino H
    Chem Pharm Bull (Tokyo); 1986 May; 34(5):2133-43. PubMed ID: 3488834
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    Thymus; 1980 Jan; 1(4-5):195-204. PubMed ID: 7445020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation by thymic hormones: studies with an avian thymic hormone.
    Murthy KK; Ragland WL
    Prog Clin Biol Res; 1984; 161():481-91. PubMed ID: 6333034
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36.
    Weksler MC; Innes JD; Goldstein G
    J Exp Med; 1978 Oct; 148(4):996-1006. PubMed ID: 81262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA; Audhya T; Kroon D; Goldstein G
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosins and other hormones of the thymus gland.
    Schulof RS; Low TL; Thurman GB; Goldstein AL
    Prog Clin Biol Res; 1981; 58():191-215. PubMed ID: 7022481
    [No Abstract]   [Full Text] [Related]  

  • 30. Early stages of human marrow lymphocyte differentiation: induction in vitro by thymopoietin and ubiquitin.
    Kagan WA; Siegal FP; Gupta S; Goldstein G; Good RA
    J Immunol; 1979 Feb; 122(2):686-91. PubMed ID: 310847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunokinetics of a single dose of thymopoietin pentapeptide.
    Di Perri T; Laghi Pasini F; Auteri A
    J Immunopharmacol; 1980; 2(4):567-72. PubMed ID: 7009760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of T lymphocyte differentiation by thymic factors.
    Touraine JL
    Mol Cell Biochem; 1981 Dec; 41():119-22. PubMed ID: 6977085
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of an immunomodulating agent on peripheral blood lymphocytes and subgingival microflora in ligature-induced periodontitis.
    Manti F; Kornman K; Goldschneider I
    Infect Immun; 1984 Jul; 45(1):172-9. PubMed ID: 6234232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of TP-5 and its analogs on skin grafts in mice.
    Szende B; Kisfaludy L; Lapis K; Dénes L; Szporny L; Nyéke O; Schön I; Hajós G; Ember J; Constantin M
    J Immunopharmacol; 1985; 7(1):67-78. PubMed ID: 3891868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro differentiation of human marrow T cell precursors by thymic factors in severe combined immunodeficiency.
    Incefy GS; O'Reilly RJ; Kapoor N; Iwata T; Good RA
    Transplantation; 1981 Oct; 32(4):299-305. PubMed ID: 6977211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of thymopoietin, ubiquitin and synthetic serum thymic factor to restore immunocompetence in T-cell deficient mice.
    Martinez D; Field AK; Schwam H; Tytell AA; Hilleman MR
    Proc Soc Exp Biol Med; 1978 Nov; 159(2):195-200. PubMed ID: 309608
    [No Abstract]   [Full Text] [Related]  

  • 38. Thymopoietin and ubiquitin.
    Audhya T; Goldstein G
    Methods Enzymol; 1985; 116():279-91. PubMed ID: 2868400
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide.
    Rentz E; Diezel W; Ehrlich A; Forner K
    Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide.
    Laghi Pasini F; Auteri A; Ceccatelli L; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):316-22. PubMed ID: 7018516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.